ABX-002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABX-002, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults [Phase 2]